Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 205: 164-175, 2018 Jul 15.
Article in English | MEDLINE | ID: mdl-29772226

ABSTRACT

AIMS: Electrolytes and trace elements dysregulation play an important role in the progression of obesity and diabetes complications. The present study was designed to evaluate the insulin sensitizing effects of peroxisomes proliferators activated receptor gamma (PPAR-γ) agonist on trace elements in obesity induced type 2 diabetes mellitus and correlate with serum visfatin. MATERIALS AND METHODS: Wistar rats were categorized into five groups. Group I served as control; Group II fed on high fat diet (HFD); Group III fed on HFD and treated with rosiglitazone (3 mg/kg) for 7 days; Group IV were T2DM rats induce by HFD and low dose of streptozotocin (i.p. 35 mg/kg); Group V was T2DM rats treated with rosiglitazone (3 mg/kg) for 7 days. Serum and tissues electrolytes levels and renal, hepatic and cardiac tissues trace elements were estimated by flame photometer and atomic absorption spectroscopy. Serum visfatin was estimated by ELISA. Pearson correlations were analyzed among fasting blood glucose (FBG), serum visfatin and tissues trace elements. KEY FINDINGS: Results of the current study showed hyponatremia, hyperkalemia, hypomagnesemia and hypercalcemia in HFD and T2DM groups. HFD and T2DM also showed elevated copper and iron levels; however, zinc and selenium levels were decreased. Rosiglitazone treatment increased the insulin sensitization and altered these changes. A Strong association was observed among FBG, serum visfatin and trace elements levels of HFD and T2DM. SIGNIFICANCE: Obesity and diabetes mellitus disturbed visfatin, electrolytes and trace elements homeostasis. Rosiglitazone treatment restored these changes. The results of the study could serve as a basis for further studies for the prevention of diabetic complications.


Subject(s)
Cytokines/blood , Diabetes Mellitus, Type 2/metabolism , Diet, High-Fat/adverse effects , Nicotinamide Phosphoribosyltransferase/blood , PPAR gamma/metabolism , Trace Elements/blood , Animals , Blood Glucose/analysis , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/etiology , Hypoglycemic Agents/pharmacology , Insulin Resistance , Male , Rats , Rats, Wistar , Rosiglitazone , Spectrophotometry, Atomic , Thiazolidinediones/pharmacology
2.
J Neuropathol Exp Neurol ; 69(3): 272-80, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20142763

ABSTRACT

The effects of radiation on neurons are incompletely characterized. We evaluated changes in the expression of neuronal nuclear and other proteins in the mouse hippocampus after 17-Gy whole-brain irradiation. Expression of neuronal nuclei (NeuN), neuron-specific enolas, prospero-related homeobox 1 (Prox1), calbindin D28k, and synaptophysin 1 in the CA1, CA3, and dentate gyrus of the hippocampus was determined by immunohistochemistry; neuronal numbers were estimated by design-based stereology. At 7 days after irradiation, there was a marked reduction of NeuN neurons in CA3. Stereologic estimates confirmed a significant reduction in NeuN neurons in CA3 at 7 days, in the dentate gyrus at 7 days, 3 weeks and 2 months, and in CA1 at 2 months compared with controls; neuron-specific enolase and prospero-related homeobox 1-positive neurons in the CA3 subregion were also decreased at 7 days. The numbers of granule and pyramidal cells identified by 4'6-diamidino-2-phenylindole nuclear staining, however, remained unchanged, and there were no changes in calbindin D28k or synaptophysin 1 immunoreactivity after irradiation. We conclude that irradiation may result in a temporary loss of neuronal protein expression in mouse hippocampus. These changes do not necessarily indicate loss of neurons and indicate the need for caution regarding the use of phenotypic markers such as NeuN to estimate changes in neuronal numbers after irradiation.


Subject(s)
Hippocampus/physiopathology , Hippocampus/radiation effects , Nerve Tissue Proteins/radiation effects , Neurons/radiation effects , Radiation Injuries, Experimental/physiopathology , Radiation, Ionizing , Animals , Biomarkers/analysis , Biomarkers/metabolism , Calbindin 1 , Calbindins , Cell Count , Cell Death/physiology , Cell Death/radiation effects , DNA-Binding Proteins , Disease Models, Animal , Down-Regulation/physiology , Down-Regulation/radiation effects , Hippocampus/metabolism , Homeodomain Proteins/metabolism , Homeodomain Proteins/radiation effects , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Nerve Degeneration/etiology , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neurons/pathology , Nuclear Proteins/metabolism , Nuclear Proteins/radiation effects , Phosphopyruvate Hydratase/metabolism , Phosphopyruvate Hydratase/radiation effects , Pyramidal Cells/metabolism , Pyramidal Cells/pathology , Pyramidal Cells/radiation effects , Radiation Injuries, Experimental/metabolism , S100 Calcium Binding Protein G/metabolism , S100 Calcium Binding Protein G/radiation effects , Synaptophysin/metabolism , Synaptophysin/radiation effects , Tumor Suppressor Proteins/metabolism , Tumor Suppressor Proteins/radiation effects
3.
Biochem Biophys Res Commun ; 341(4): 1184-92, 2006 Mar 24.
Article in English | MEDLINE | ID: mdl-16460673

ABSTRACT

The p75 neurotrophin receptor (p75(NTR)) is a death receptor which belongs to the tumor necrosis factor receptor super-family of membrane proteins. This study shows that p75(NTR) retarded cell cycle progression by induced accumulation of cells in G0/G1 and a reduction in the S phase of the cell cycle. The rescue of tumor cells from cell cycle progression by a death domain deleted (DeltaDD) dominant-negative antagonist of p75(NTR) showed that the death domain transduced anti-proliferative activity in a ligand-independent manner. Conversely, addition of NGF ligand rescued retardation of cell cycle progression with commensurate changes in components of the cyclin/cdk holoenzyme complex. In the absence of ligand, p75(NTR)-dependent cell cycle arrest facilitated an increase in apoptotic nuclear fragmentation of the prostate cancer cells. Apoptosis of p75(NTR) expressing cells occurred via the intrinsic mitochondrial pathway leading to a sequential caspase-9 and -7 cascade. Since the death domain deleted dominant-negative antagonist of p75(NTR) rescued intrinsic caspase associated apoptosis in PC-3 cells, this shows p75(NTR) was integral to ligand independent induction of apoptosis. Moreover, the ability of ligand to ameliorate the p75(NTR)-dependent intrinsic apoptotic cascade indicates that NGF functioned as a survival factor for p75(NTR) expressing prostate cancer cells.


Subject(s)
Caspases/physiology , Cell Cycle/drug effects , Nerve Tissue Proteins/physiology , Prostatic Neoplasms/physiopathology , Receptors, Nerve Growth Factor/physiology , Apoptosis/drug effects , Cell Line, Tumor , Humans , In Situ Nick-End Labeling , Male , Nerve Growth Factor/pharmacology
4.
Int J Cancer ; 105(1): 47-52, 2003 May 20.
Article in English | MEDLINE | ID: mdl-12672029

ABSTRACT

p75(NTR) was identified as a tumor and metastasis suppressor that functions in part via induction of apoptosis in tumor cells. To examine p75(NTR)-dependent apoptosis in tumor cells, we demonstrated that a dose-dependent increase in p75(NTR) expression was associated with a concomitant increase in the mitochondrial proapoptotic effector proteins Bad, Bax and Bik and a decrease in the mitochondrial prosurvival effector proteins phospho-Bad, Bcl-2 and Bcl-x(L). Significantly, p75(NTR)-dependent induction of cytochrome c release from the mitochondria occurred during CHX potentiation of apoptosis. Furthermore, p75(NTR) expression largely suppressed expression of IAP-1 and induced cleavage of procaspase-9 and procaspase-7 but not of procaspases 2, 3, 6, 8 and 10. A specific peptide inhibitor of procaspase-9 cleavage also inhibited cleavage of procaspase-7, indicating that caspase-7 is downstream of caspase-9. As end points of apoptosis, we observed p75(NTR)-dependent annexin V binding to the plasma membrane, an indicator of early apoptotic events, and Hoechst staining of DNA nuclear fragmentation, an indicator of late apoptotic events, whereas control tumor cells that lack expression of the p75(NTR) protein did not exhibit either of these apoptotic markers. Together, these results delineate the mitochondria-mediated apoptotic pathway of the p75(NTR) tumor-suppressor gene product.


Subject(s)
Apoptosis , Caspases/metabolism , Receptors, Nerve Growth Factor/metabolism , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/pathology , Annexin A5/pharmacology , Caspase 7 , Caspase 9 , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cytochrome c Group/metabolism , Humans , Immunoblotting , Mitochondria/metabolism , Receptor, Nerve Growth Factor , Time Factors , Transfection , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...